Gut Microbiota Changes during Dimethyl Fumarate Treatment in Patients with Multiple Sclerosis
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24032720 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Caterina Ferri und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience and Rehabilitation, University of Ferrara, 44121 Ferrara, Italy. Hauptthemen laut MEDLINE: Multiple Sclerosis, Gastrointestinal Microbiome, Gastrointestinal Diseases, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Multiple Sclerosis Italian Foundation (FISM), University of Ferrara, Multiple Sclerosis Italian Foundation, FISM.
Abstract (Originalsprache)
The gut microbiota is involved in the development of the immune system and can modulate the risk for immune-mediated disorders such as multiple sclerosis (MS). Dysbiosis has been demonstrated in MS patients and its restoration by disease-modifying treatments (DMTs) is hypothesized. We aimed to study the changes in gut microbiota composition during the first 6 months of treatment with dimethyl fumarate (DMF), an oral DMT, and to identify the microorganisms associated with DMF side effects. We collected and analyzed the gut microbiota of 19 MS patients at baseline and after 1, 3, and 6 months of DMF treatment. We then cross-sectionally compared gut microbiota composition according to the presence of gastrointestinal (GI) symptoms and flushing. Overall, the gut microbiota biodiversity showed no changes over the 6-month follow-up. At the genus level, DMF was associated with decreased Clostridium abundance after 6 months. In subjects reporting side effects, a higher abundance of Streptococcus, Haemophilus, Clostridium, Lachnospira, Blautia, Subdoligranulum, and Tenericutes and lower of Bacteroidetes, Barnesiella, Odoribacter, Akkermansia, and some Proteobacteria families were detected. Our results suggest that gut microbiota may be involved in therapeutic action and side effects of DMF, representing a potential target for improving disease course and DMT tolerability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neuroscience and Rehabilitation, University of Ferrara, 44121 Ferrara, Italy.
- Department of Neuroscience and Rehabilitation, St. Anna University Hospital, 44124 Ferrara, Italy.
- Interdepartmental Research Center for the Study of Multiple Sclerosis and Inflammatory and Degenerative Diseases of the Nervous System, University of Ferrara, 44121 Ferrara, Italy.
- IRCCS Istituto delle Scienze Neurologiche di Bologna, 40139 Bologna, Italy.
- Department of Medicine and Surgery, University of Parma, 43124 Parma, Italy.
- Microbiome Research Hub, University of Parma, 43124 Parma, Italy.
ORCID-Profile: Caterina Ferri, Massimiliano Castellazzi, Nicola Merli, Elisa Baldin
Förderung
- Multiple Sclerosis Italian Foundation (FISM)
- University of Ferrara
- Multiple Sclerosis Italian Foundation, FISM
Zitieren
APA
Ferri, C., Castellazzi, M., Merli, N., Laudisi, M., Baldin, E., Baldi, E., Mancabelli, L., Ventura, M., & Pugliatti, M. (2023). Gut Microbiota Changes during Dimethyl Fumarate Treatment in Patients with Multiple Sclerosis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24032720
Vancouver
Ferri C, Castellazzi M, Merli N, Laudisi M, Baldin E, Baldi E, et al. Gut Microbiota Changes during Dimethyl Fumarate Treatment in Patients with Multiple Sclerosis. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24032720
BibTeX
@article{Ferri2023,
author = {Ferri, Caterina and Castellazzi, Massimiliano and Merli, Nicola and Laudisi, Michele and Baldin, Elisa and Baldi, Eleonora and Mancabelli, Leonardo and Ventura, Marco and Pugliatti, Maura},
title = {Gut Microbiota Changes during Dimethyl Fumarate Treatment in Patients with Multiple Sclerosis},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24032720}
}
EUVIMED